Canada markets close in 33 minutes

Genix Pharmaceuticals Corporation (GENX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0500+0.0050 (+11.11%)
As of 01:44PM EDT. Market open.
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-10-31
2022-10-31
2021-10-31
2020-10-31
Cash flows from operating activities
Net Income
-4,228
-4,396
-1,074
-1,653
-718.663
Depreciation & amortization
409.542
547.42
564.173
536.611
361.567
Stock based compensation
-
59.21
258.825
809.373
96.923
Change in working capital
20.299
56.24
-5.673
-123.762
65.139
Inventory
9.549
12.208
-166.486
-4.835
0
Accounts Payable
-
29.112
175.986
-93.524
75.365
Other working capital
-211.773
-220.674
-222.917
-428.312
-195.034
Other non-cash items
66.331
49.402
8.609
1.982
-
Net cash provided by operating activites
-211.773
-220.674
-219.578
-428.312
-195.034
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-3.339
-
-
Acquisitions, net
-
-
-
-
-8
Net cash used for investing activites
-
0
-3.339
0
-8
Cash flows from financing activities
Debt repayment
3
0
-20.757
-14
-5.4
Common stock issued
-
-
-
-
1,006
Other financing activites
-
-58.839
-54.994
-115.482
-132.79
Net cash used privided by (used for) financing activities
179.782
223.038
93.371
-129.482
868.294
Net change in cash
-31.99
2.364
-129.546
-557.794
665.26
Cash at beginning of period
41.287
9.267
138.813
696.607
31.347
Cash at end of period
9.297
11.631
9.267
138.813
696.607
Free Cash Flow
Operating Cash Flow
-211.773
-220.674
-219.578
-428.312
-195.034
Capital Expenditure
-
-
-3.339
-
-
Free Cash Flow
-211.773
-220.674
-222.917
-428.312
-195.034